ING Group’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-32,818
Closed -$1.15M 476
2019
Q2
$1.15M Buy
32,818
+41
+0.1% +$1.33K 0.02% 353
2019
Q1
$961K Sell
32,777
-21,422
-40% -$607K 0.02% 325
2018
Q4
$1.39M Buy
+54,199
New +$1.88M 0.03% 273
2018
Q1
Sell
-12,325
Closed -$402K 719
2017
Q4
$402K Buy
12,325
+2,321
+23% +$80.4K 0.01% 566
2017
Q3
$478K Buy
10,004
+709
+8% +$34.6K 0.01% 495
2017
Q2
$459K Buy
+9,295
New +$412K 0.01% 524

Other funds holding ACHC

ING Group's ACHC Position: Q3 2019 in Review

ING Group sold out of Acadia Healthcare (ACHC) in Q3 2019, closing a stake of 32,818 shares — an estimated $1.15M sold.

ING Group first reported a position in ACHC in Q2 2017 and held it in 6 quarters. The position peaked at $1.39M in Q4 2018. 226 funds tracked by Wall St. Rank hold ACHC as of Q3 2019.

  • ING Group reported no remaining Acadia Healthcare position as of Q3 2019 after selling out during the quarter.
  • ING Group sold 32,818 Acadia Healthcare shares in Q3 2019, an estimated $1.15M.
  • ING Group first reported a position in Acadia Healthcare in Q2 2017 and held it in 6 quarters.
  • ING Group's Acadia Healthcare position peaked at $1.39M in Q4 2018.
  • 226 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2019.

Based on ING Group's 13F filing for Q3 2019, filed 8 Nov 2019.